Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
about
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Next generation of immune checkpoint therapy in cancer: new developments and challenges.The Immune Landscape of Cancer.Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment.Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers.Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection.Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples.Pan-cancer deconvolution of tumour composition using DNA methylationKeeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in CancerEndogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinomaKidney cancer: The next decadeCheckpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challengesPrognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New EvidencesMechanisms of acquired resistance to rapalogs in metastatic renal cell carcinomaImmunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer
P2860
Q47557998-80BA695B-B335-4D1F-AACE-2326071FDA22Q52653710-7385FA6B-5FC3-457F-B8DD-EF2FB066C545Q52720878-92C54663-0AA5-4755-BFC4-FBD6D3EA980CQ55114350-DDF95BA8-2465-4164-9300-8A5B6712638AQ55395213-A80BE37D-13B3-49E5-9218-12C03D8B221FQ55418935-F30DB950-69B5-4FED-A2A7-7575D73764CFQ55453667-C4661D4F-2E83-4E7E-8561-F240CF9C5C43Q56890466-5B8E30A4-D5B9-4756-95F6-5E112C53880AQ56891212-E56DDE19-4460-45F3-BB77-1119C6E36C9FQ56929146-812F4071-FDE2-416C-84C6-B0DC5E74D463Q57141762-01F76C38-B20C-470C-91F9-64B96201E2E6Q57162847-7E81D387-5FDD-4868-8315-A798A3F1AB55Q57191808-6A5CCF6D-D15B-4386-B610-EBB743CB1695Q58693750-4BA23EBB-EB0F-483A-B0F5-4477A185F427Q59129654-2EDADF26-1631-4F36-87D3-70CCD9F9423F
P2860
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Genomic correlates of response ...... ear cell renal cell carcinoma.
@en
Genomic correlates of response ...... ear cell renal cell carcinoma.
@nl
type
label
Genomic correlates of response ...... ear cell renal cell carcinoma.
@en
Genomic correlates of response ...... ear cell renal cell carcinoma.
@nl
prefLabel
Genomic correlates of response ...... ear cell renal cell carcinoma.
@en
Genomic correlates of response ...... ear cell renal cell carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Genomic correlates of response ...... ear cell renal cell carcinoma.
@en
P2093
Charles G Drake
Christine Horak
Craig Norton
Dana Cullen
Diana Miao
Marios Giannakis
P2860
P304
P356
10.1126/SCIENCE.AAN5951
P407
P50
P577
2018-01-04T00:00:00Z